WS09.01 Impact of long-term elexacaftor/tezacaftor/ivacaftor therapy on lung infection microbiota in adults with cystic fibrosis.

Autor: Gavillet, H.1 (AUTHOR), Hatfield, L.2 (AUTHOR), Daniels, T.3 (AUTHOR), Horsley, A.4 (AUTHOR), Jones, A.4 (AUTHOR), Francis, N.4 (AUTHOR), Lord, R.4 (AUTHOR), Einarsson, G.5 (AUTHOR), Duckers, J.6 (AUTHOR), Rivett, D.7 (AUTHOR), van der Gast, C.1,8 (AUTHOR)
Zdroj: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS16-S16. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: